Lucid Diagnostics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Lucid Diagnostics, Inc. | LUCD - NASDAQ |
$14.00-$16.00 | $14.00 | $12.75 | 5 million | 10/14/2021 |
| Cantor, Canaccord Genuity | ||||||
Co-Manager(s): BTIG, Needham | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-09-22 Terms Added 2021-10-07 | ||||||
Lucid Diagnostics, Inc. Quote & Chart - Click for current quote - LUCD
IPO Boutique aggregates information on public companies and private companies, such as "LUCD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Lucid Diagnostics, Inc. (adapted from Lucid Diagnostics, Inc. prospectus):
They are are a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are are a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LUCD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.